ライフサイエンスコーパス: referral center

1 ferred to Oslo University Hospital (tertiary referral center).

2 ectional study at a single academic tertiary referral center.

3 0 to December 31, 2012 at a large university referral center.

4 ic phenotypes at a university-based tertiary referral center.

5 er 1, 2011, to April 18, 2016 at an academic referral center.

6 t an urban, academic ED at a quaternary care referral center.

7 ervational cohort study at a single national referral center.

8 5) for vascular anomalies at a tertiary care referral center.

9 June to November 2015 at a tertiary clinical referral center.

10 to December 1, 2014, at a tertiary academic referral center.

11 8, 2006, until June 17, 2015, at a tertiary referral center.

12 ction of autoantibodies in a neuroimmunology referral center.

13 nce tomography, at a tertiary ophthalmologic referral center.

14 ed for at Vanderbilt University, an academic referral center.

15 ge academic inner-city trauma and quaternary referral center.

16 al Sloan-Kettering Cancer Center, a tertiary referral center.

17 th MRE in pregnant CD patients in a tertiary referral center.

18 th follow-up of 5 to 25 months at a tertiary referral center.

19 adiation of normal human skin at an academic referral center.

20 utpatients routinely followed up at a single referral center.

21 arge cohort of celiacs diagnosed in a single referral center.

22 010, through October 31, 2012, at a tertiary referral center.

23 arative analysis was conducted at a tertiary referral center.

24 ter syndrome (RS) over a 10-year period at a referral center.

25 March 31, 2013, in a tertiary hepatobiliary referral center.

26 evaluated by a single surgeon at a tertiary referral center.

27 a new technique was conducted at a tertiary referral center.

28 spective medical record review at a tertiary referral center.

29 ist Photobiology Unit of a tertiary academic referral center.

30 rol participants at a tertiary ophthalmology referral center.

31 2002, and December 31, 2012, at an academic referral center.

32 onal case series was conducted at a tertiary referral center.

33 ry of microbial keratitis seen at a tertiary referral center.

34 tive case series was conducted at a tertiary referral center.

35 cranial and spinal operations in a tertiary referral center.

36 hildren with cataract operated at a tertiary referral center.

37 T, were identified at a single tertiary-care referral center.

38 sis, confirmed by histology, from a tertiary referral center.

39 ere prospectively recruited at an outpatient referral center.

40 rtrophic cardiomyopathy cohort at a tertiary referral center.

41 The authors are from a pediatric tertiary referral center.

42 atory disease in a university-based tertiary referral center.

43 nosed with posterior scleritis in a tertiary referral center.

44 aculopathy by a single surgeon at a tertiary referral center.

45 septal ablation performed in a tertiary HCM referral center.

46 patients admitted with encephalitis to this referral center.

47 y and routine prophylactic CND at a tertiary referral center.

48 ed at a tertiary hypertrophic cardiomyopathy referral center.

49 tients evaluated at an academic Lyme disease referral center.

50 A community hospital that is a cardiac referral center.

51 C)>or=32 microg/ml) lung disease at a single referral center.

52 e, retrospective case series at a University Referral Center.

53 lity treatments in a national retinoblastoma referral center.

54 ase series at a single institution, tertiary referral center.

55 The study was performed in a tertiary referral center.

56 2011, through April 22, 2016, at an academic referral center.

57 h MRI metrics was conducted at a tertiary MS referral center.

58 primary open angle glaucoma in our tertiary referral center.

59 ween 2013 and 2015 at a single tertiary care referral center.

60 , 2014, to October 31, 2015, at a university referral center.

61 with 35 dexamethasone implants at a tertiary referral center.

62 HCM without prior SCD event, from 2 tertiary referral centers.

63 ts (1329 eyes) were enrolled from 3 academic referral centers.

64 y 2015, in neurology departments at tertiary referral centers.

65 , MSH6, and PMS2) using databases from 13 US referral centers.

66 d 76,817 patients were hospitalized at three referral centers.

67 iatric PAH patients differed between 3 major referral centers.

68 unselected CD children diagnosed by national referral centers.

69 l multicenter cohort study among MS tertiary referral centers.

70 ith RFA from 2003 through 2011 at 3 tertiary referral centers.

71 9 patients (11 eyes) with AMN at 6 tertiary referral centers.

72 he outer plexiform layer (OPL) at 6 tertiary referral centers.

73 h herpes virus infection, seen at 2 tertiary referral centers.

74 d sample collection and ulterior analysis at referral centers.

75 However, most studies involved referral centers.

76 and most reports describe the experience in referral centers.

77 ing current therapeutic regimens at tertiary referral centers.

78 oming the preferred option at major tertiary referral centers.

79 asingly becoming an option at major tertiary referral centers.

80 quiescent CNV were analyzed in 2 high-volume referral centers.

81 imated incidence of 0.0025 to 0.014 in large referral centers.

82 graphic diagnosis of LVNC underwent CMR at 5 referral centers.

83 entified from a pool of patients at 2 retina referral centers.

84 m hepatitis B virus DNA in European tertiary referral centers.

85 In our tertiary care referral center, 164 subjects with preinvasive lesions w

86 = 486) having curative surgery at a tertiary referral center (2002-2011) was conducted.

87 Even in the setting of a tertiary care referral center, 21.6% of these readmissions were to non

88 try of patients with BAV treated at tertiary referral centers, 2118 patients with BAV were evaluated.

89 At 3 tertiary referral centers, 228 patients with non-ischemic cardiom

90 ve cohort study performed at a tertiary care referral center, 50 African American patients 60 years o

91 f 500 eyes that underwent DMEK at a tertiary referral center, 7 eyes developed typical clinical signs

92 al transfers from less resourced ICUs to the referral center, a trend that is not readily explained b

93 efore, strict dermatologic surveillance in a referral center aided by digital follow-up is mandatory,

94 Interventional case series at a tertiary referral center among 16 patients.

95 the DCTN1 gene in familial forms of PSP at a referral center among 21 patients with familial PSP-like

96 2012, to December 30, 2014, at a private MS referral center among 50 obese patients with MS who also

97 ve cohort study at an academic ophthalmology referral center among 507 patients with uveal melanoma w

98 hological case series at a tertiary eye care referral center among patients who underwent Boston type

99 and December 31, 2013, at tertiary academic referral centers among 9 patients (age range, 13-47 year

100 sessments was performed at an urban tertiary referral center and a regional center from January 1, 20

101 rom 2 separate institutions: a tertiary-care referral center and an outpatient clinic.

102 ve patients treated with HDM/SCT at a single referral center and compared outcomes for patients with

103 In vivo PET at tertiary neuroscience referral center and ex vivo immunocytochemistry of autop

104 r 2009 and November 2011 at an institutional referral center and reading center of patients with trea

105 Patients were recruited from referral centers and general neurology clinics in public

106 A combination of 17 tertiary referral centers and private practices worldwide contrib

107 ctious anterior scleritis seen at 2 tertiary referral centers and studied the factors associated with

108 y at the Radboudumc (tertiary ophthalmologic referral center) and the European Genetic Database for p

109 Massachusetts General Hospital (tertiary referral center) and two affiliated community hospitals.

110 general community clinics, primary care and referral centers, and ambulatory and hospitalized care.

111 other patients commonly seen in Lyme disease referral centers, and were related to poor functional ou

112 follow-up care recommendations developed at referral centers are not being adhered to in the communi

113 at receives data from teaching hospitals and referral centers, as well as several pneumology, dermato

114 007, and December 31, 2013, at a dermatology referral center at a single institution.

115 or Fuchs endothelial dystrophy at a tertiary referral center, best spectacle-corrected visual acuity

116 ciency virus [HIV] status) seen in a uveitis referral center between 1984 and 2014 were reviewed.

117 s of 63 patients who presented to a tertiary referral center between 2006 and 2015 with culture-posit

118 crobiota transplantation (FMT) at a tertiary referral center between 2011 and 2014 to determine risk

119 ive data on 682,704 patients from a tertiary referral center between 2011 and 2015, and identified hy

120 Newcastle mitochondrial disease specialized referral center between January 1, 2000, and January 31,

121 underwent pancreatectomy at a tertiary care referral center between January 1, 2005, and December 2,

122 going abdominal surgery for CD at a tertiary referral center between January 1998 and June 2014 were

123 nts undergoing genetic testing at a tertiary referral center between July 2005 and November 2010.

124 ancer patients who presented to our tertiary referral center between March 2011 and February 2015.

125 <21 years) who were evaluated at a tertiary referral center between November 1, 1975, and July 1, 20

126 y ill burn patients admitted to our tertiary referral center between October 2013 and February 2016 w

127 ive pediatric PAH patients who visited the 3 referral centers between 2000 and 2010 were included.

128 ic endovascular aortic repair for rDTAA at 7 referral centers between 2002 and 2009.

129 ptibility genes from 8 independent worldwide referral centers between January 2009 and June 2010.

130 1 consecutive patients enrolled at 3 Italian referral centers between June and November 2014 (end of

131 At 2 referral centers between October 1, 1995, and May 31, 20

132 analyzed the IPMNs from 2 pancreatic cancer referral centers by correlating the MUC expression, hist

133 ctive chart review of patients at a tertiary referral center compares characteristics and clinical fe

134 Databases from 2 referral centers comprising 2100 HCM patients were inter

135 tudy included patients from 25 ophthalmology referral centers diagnosed with TB uveitis and treated w

136 In two tertiary referral centers, donors undergoing left-sided nephrecto

137 eyes) who were treated at a single tertiary referral center during a 10-year period.

138 ohort study at an academic hospital tertiary referral center evaluating the growth rate of hepatic he

139 all patients followed at the French National Referral Center for acute Q fever were included in a coh

140 hospital in the Middle East and the tertiary referral center for all hospitals in Egypt that happened

141 onducted between 2011 and 2014 at a tertiary referral center for ALS.

142 and March 2015 at a tertiary dermatological referral center for anal cancer screening.

143 was conducted using records from a tertiary referral center for autoimmune bullous disorders.

144 al Research (USAISR) Burn Center serves as a referral center for civilians and is the sole center for

145 hotodamaged skin was conducted in a tertiary referral center for dermatology between January 1, 2009,

146 At a tertiary care referral center for diabetic eye disease, a retrospectiv

147 ries of 76 patients presenting to a tertiary referral center for evaluation of chronic progressive ce

148 ed up with a family presenting to a tertiary referral center for evaluation of HSP for a decade until

149 the clinical database of a large quaternary referral center for genomic medicine in the Northwest of

150 des Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious

151 etween March 2002 and May 2015 in a tertiary referral center for multiple sclerosis, in collaboration

152 etrospective case series in an institutional referral center for multiple sclerosis, including 30 pat

153 cardiomyopathy patients from a tertiary care referral center for mutations in the PLN gene.

154 Academic tertiary referral center for neurodegenerative disorders in 17 as

155 nal cohort study was conducted at a tertiary referral center for neurological diseases in Rio de Jane

156 and/or eye abnormalities, from a US tertiary referral center for neurological diseases using multiple

157 ried the medical records of a large tertiary referral center for patients with a history of prior hea

158 1, 2012, to July 30, 2015, in an outpatient referral center for patients with neurodegenerative dise

159 trial with a 2-year follow-up at a tertiary referral center for pediatric obesity in the Netherlands

160 patients of the 2004 to 2014 French National Referral Center for Q fever database.

161 ll patients diagnosed in the French National Referral Center for Q fever from January 2007 to Decembe

162 y 2007 and April 2014 at the French National Referral Center for Q fever.

163 enter, Nijmegen, the Netherlands, a tertiary referral center for retinal disorders.

164 collection and explorations made in a single referral center for sickle cell disease in 2016.

165 n a case-control study conducted at a French referral center for SLE and antiphospholipid syndrome, 2

166 pective cohort study conducted in a tertiary referral center for the diagnosis and follow-up of gastr

167 rban catchment area and serves as a tertiary referral center for the province of Ontario).

168 Eyes with uveitis seen at a single tertiary referral center for which ME was the principal cause of

169 ecutive LMNA mutation carriers followed at 5 referral centers for a median of 7 years from first clin

170 ategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to December 2016

171 Referral centers for HPB disease have been used as a str

172 study, 2 groups of patients from 2 tertiary referral centers for melanoma (Sydney Melanoma Diagnosti

173 21 private and 2 institutional US ambulatory referral centers for MMS.

174 ined contemporary patient cohorts at 3 major referral centers for pediatric PAH (New York [NY], Denve

175 study was conducted (1992-2010) in tertiary referral centers for treatment of cutaneous melanoma.

176 Patients prospectively registered in two referral centers for vascular liver disorders were eligi

177 s requires adequate technology, available at referral centers, for amyloid typing.

178 enous fungal endophthalmitis at a university referral center from 1990 to 2010 were reviewed.

179 d database of VGAM cases managed at a single referral center from 2000 to 2014.

180 t study carried out at a large tertiary care referral center from 2004 to 2008 screened all adult pat

181 prospective case series at an institutional referral center from December 1, 2011, through February

182 ents who presented to a single tertiary care referral center from December 24, 1987, to June 18, 2010

183 gical oncology) at an academic tertiary care referral center from January 1, 1978, to December 31, 20

184 ently undergoing patch testing at a tertiary referral center from January 1, 2012, through November 3

185 nt recipients was recruited from a Brazilian referral center from January 2005 to December 2009; all

186 eatic surgery at a university-based tertiary referral center from July 1, 2013, through June 30, 2015

187 ed uveitis patients attending a tertiary eye referral center from Madrid (Spain) between 1989 and 201

188 spective cross-sectional study at a tertiary referral center from March 1, 2012, to January 1, 2013,

189 oing curative RT at a single academic cancer referral center from October 1, 2003, to August 31, 2013

190 o received ipilimumab at 9 academic tertiary referral centers from January 1, 2012, through August 1,

191 Hershey Medical Center, an academic tertiary referral center, from May 1, 2011, through November 30,

192 A multicenter retrospective study (13 French referral centers, from 1980-2009) included 141 children

193 , to December 31, 2012, at an FTD specialist referral center (FRONTIER).

194 rophic cardiomyopathy evaluated at 2 Italian referral centers >3 decades.

195 The use of surveillance-only strategies at referral centers has yielded survival outcomes comparabl

196 rred to and managed at a tertiary university referral center have benefited from advances in HF medic

197 cialized surgical procedure are scarce, some referral centers have accumulated extensive experience.

198 uncommon surgical procedure are scarce, some referral centers have accumulated extensive experience.

199 ween October 1985 and May 2014 at a tertiary referral center hosting the Dutch Cutaneous Lymphoma Reg

200 med at a corneal and ocular surface diseases referral center in 2010.

201 a Creu i Sant Pau, an institutional practice referral center in Barcelona, Spain, between May 1, 2015

202 r trial was conducted in a neonatal tertiary referral center in Germany.

203 This is a case report from an academic referral center in Miami, Florida, of a woman in her 60s

204 health center in Seattle, Washington, and a referral center in Miami, Florida.

205 atment with DFO were recruited in a tertiary referral center in Milan, Italy, and were investigated.

206 iral therapy (ART) at the main pediatric ART referral center in Mozambique.

207 e cohort study performed at an institutional referral center in New York.

208 the diagnostic criteria for NS in a tertiary referral center in Paris, France, from January 1, 1990,

209 c blepharokeratoconjunctivitis at a tertiary referral center in Singapore from 1991 through 2010 were

210 onal study of neonatal admissions at a large referral center in sub-Saharan Africa to determine the p

211 t results from patients attending a tertiary referral center in the UK.

212 dy, 2 analyses were performed at an academic referral center in the upper Midwest.

213 010 through February 2013 at a tertiary care referral center in Utrecht, the Netherlands.

214 f the Xpert MTB/RIF assay at a tertiary care referral center in Zambia, a country where the burden of

215 2-period crossover study at 7 neuromuscular referral centers in 4 countries of 59 patients with NDMs

216 ts 6 years and older at baseline at tertiary referral centers in Europe, the United States, and the U

217 ruited from 8 hospital-based thyroid-disease referral centers in Italy between 2006 and 2008.

218 s conducted on patients seen at two tertiary referral centers in Mexico.

219 ong adult inpatients attending tertiary care referral centers in other countries with a high burden o

220 g Gung Memorial Hospital, one of the biggest referral centers in Taiwan.

221 Developing Brain-Methylphenidate) among ADHD referral centers in the greater Amsterdam area in the Ne

222 ; 67% male) were identified from 10 tertiary referral centers in the Netherlands and Belgium.

223 r older and had a visit for HS at 1 of the 2 referral centers in the past 2 years (from January 1, 20

224 l trends in cases were derived from national referral centers in the period 2004-2014.

225 e case series of 21 patients from 5 tertiary referral centers in the United Kingdom and Australia wit

226 ctive cohort study was conducted at tertiary referral centers in the United States and Europe.

227 doscopic examination for BE at tertiary care referral centers in the United States and Europe.

228 ectional survey study of 154 patients from 2 referral centers in the United States and in Denmark was

229 rimary data were accumulated from 6 tertiary referral centers in the United States, Belgium, United K

230 ered enrollment into the study at 5 academic referral centers in the United States; 13 declined parti

231 ntibodies in 380 patients with myositis from referral centers in the US.

232 A retrospective case series in a tertiary referral center included 100 consecutive patients underg

233 onal cohort analysis performed at a tertiary referral center included 43 laser-naive patients with PD

234 ational study performed at 2 ocular oncology referral centers included 339 patients in a primary coho

235 hns Health Center, a tertiary-level melanoma referral center, included 1623 patients with melanoma di

236 ar randomized controlled trial at a tertiary referral center, including 263 adults (178 with CD and 8

237 Retrospective observational case series at a referral center involving 17 eyes of 17 patients.

238 logists, and geneticists from retinoblastoma referral centers located in various geographic regions w

239 d opinions before initial treatment at local referral centers may be helpful in minimizing reassignme

240 Italian tertiary referral center medical-surgical ICU.

241 At a large tertiary care referral center, midterm quality outcomes after robotic

242 nder the National Cancer Institute Treatment Referral Center network nationwide.

243 gy department affiliated with the French NF1 referral center network.

244 Single-site, tertiary care referral center observational study of 1145 of 2197 cons

245 ve, noncomparative case series at a tertiary referral center (Ocular Oncology Service of Wills Eye Ho

246 etrospective analysis at a tertiary academic referral center of 100 consecutive patients undergoing p

247 Prospective case series in a referral center of 22 eyes from 18 patients (mean age, 7

248 etrospective review at a university tertiary referral center of all pregnant patients seen with abdom

249 Cross-sectional study at a referral center of chronobiology among 12 young healthy

250 al study of 12 young healthy volunteers at a referral center of chronobiology.

251 ry translational analysis at a tertiary care referral center of patients with completely treated HER2

252 s-sectional study of CD in the Mediterranean referral centers offers a puzzling picture of the capaci

253 period 1998 to 2015 from the single national referral center on autoimmune bullous diseases.

254 Multicenter (8 endoscopic referral centers), open-label, parallel, randomized clin

255 keratoplasty recipients at a single tertiary referral center over 20 years.

256 5 autopsies examined at an academic tertiary referral center over 21 years were tabulated for histopa

257 Thirty-six French MS tertiary referral centers participated.

258 Previous reports have focused on referral center patients and it is unclear whether these

259 At a single tertiary referral center, patients with HCC were randomly assigne

260 ary 7, 2014, to July 15, 2015, in a tertiary referral center pediatric dermatology clinic and in 2 pr

261 Participants were enrolled from a single referral center recruiting nationwide in Norway.

262 ty of Pennsylvania Health System, a tertiary referral center serving a population with a high proport

263 The database of a national referral center specialized in genetic sensory diseases

264 h additional wedge resections, at a tertiary referral center specialized in laparoscopic hepato-pancr

265 ters on the basis of results from a tertiary referral center specializing in complex filter retrieval

266 These data, from an ocular tertiary referral center, suggest that conjunctival tumors in chi

267 The study took place among eight U.S. referral centers that are part of the DILIN.

268 rupture may be safely undertaken at tertiary referral centers that have expertise in managing connect

269 were obtained from patients from 23 tertiary referral centers throughout the United States and from r

270 to compare results and value of care between referral centers, to perform health technology assessmen

271 lyzed at a tertiary academic ocular oncology referral center using a customized bioinformatic pipelin

272 e triage of high-risk patients to designated referral centers using a validated prehospital risk scor

273 In a single-blind study performed at 2 referral centers we assigned 148 patients with severe no

274 spective study, patients in a hospital-based referral center were recruited from March 1, 2010, throu

275 adult patients treated in a single tertiary referral center were retrospectively identified and incl

276 Patients undergoing ERC at our tertiary referral center were retrospectively included.

277 traumatic macular holes at a single tertiary referral center were reviewed.

278 1/1/2000 to 12/31/2009 at a single tertiary referral center were reviewed; clinical information was

279 between January 2011 and September 2016 in 3 referral centers were included.

280 atients with episcleritis seen at 2 tertiary referral centers were reviewed and their clinical featur

281 Thirty-six patients with RRMS from referral centers were screened; 25 were enrolled.

282 mentia Cohort (longitudinal cohort, tertiary referral center) were studied.

283 ping surgical procedures at a large tertiary-referral center where overlapping surgery is performed.

284 -certified dermatologist at a large tertiary referral center, where ENFD testing became a routine par

285 -certified dermatologist at a large tertiary referral center, where ENFD testing became a routine par

286 neoplasia should be centralized in tertiary referral centers, where procedures are performed under o

287 of 263 patients at a large, urban, tertiary referral center who underwent either dynamic parathyroid

288 sis of consecutive SSc patients from 2 large referral centers who had PH-ILD confirmed by right-sided

289 fants with unilateral congenital cataract in referral centers who were between ages 1 and 6 months at

290 Patients consecutively admitted to three referral centers who were receiving best supportive care

291 atients with esophageal cancer in a tertiary referral center, who underwent nCRT (5 weekly courses of

292 secutive patients with PXE from a university referral center whose diagnosis has been confirmed by ge

293 the clinical experience of the authors in a referral center with a cohort of patients affected by ju

294 was evaluated in this complex scenario at a referral center with a multidisciplinary IE unit.

295 patients who were treated in a single 3(rd) referral center with bevacizumab using a loading dosage

296 ric index ranged from 1 (access to principal referral center with cardiac catheterization service </=

297 a Hospital, a large, Canadian, tertiary care referral center with expertise in neurology and HSCT, fr

298 This study involved 5 tertiary referral centers with a specialized adult congenital hea

299 liance with follow-up protocols developed at referral centers within the community.

300 nosed with PEVAC were identified at 4 retina referral centers worldwide and underwent complete ophtha